Document:

omnibio10k_ex1462709.htm

    
 

    Exhibit
10.14

    

    FORM
OF INVESTOR WARRANT

    

    WARRANT
NO.__

    

    WARRANT
TO PURCHASE SHARES

    OF
COMMON STOCK OF

    Across
America Financial Services, Inc

    (pending
name change to Omni Bio Pharmaceutical, Inc.)

    

    

    Warrant
to Purchase _____ Shares

    (subject
to adjustment as set forth herein)

    

    

    Exercise
Price $0.50 Per Share

    (subject
to adjustment as set forth herein)

    

    VOID
AFTER 5 P.M., MST, TIME, March 31, 2014

    

    

    THE
SECURITIES REPRESENTED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE "ACT") OR REGISTERED OR QUALIFIED UNDER
ANY OTHER APPLICABLE FEDERAL OR STATE SECURITIES LAWS.  THESE
SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, OR OTHERWISE TRANSFERRED, IN WHOLE
OR IN PART, EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR
QUALIFICATION FILED IN ACCORDANCE WITH THE ACT OR PURSUANT TO AN EXEMPTION FROM
REGISTRATION UNDER THE ACT.

    

    

    Across
America Financial Services, Inc. (whose name is being changed to Omni Bio
Pharmaceutical, Inc.), 5350 S. Roslyn St., Suite 400, Greenwood Village,
Colorado 80111 (the "Company"), hereby certifies that, for value received,
«Name», «Address», «City_», «State_» «Zip», (who, together with any subsequent
holder of the Warrant, is referred to as the "Holder"), is entitled, subject to
the terms and conditions set forth below, to purchase from the Company at any
time before 5 p.m., MST time, on March 31, 2014 ("Expiration Date")(five
years from date of issue), up to «Amount_50_word» («Amount_50») shares of the
Company's $.001 par value Common Stock (the "Shares") at a purchase price of
$0.50 per Share (the "Exercise Price").

    

    The term
"Warrant" as used herein shall include this Warrant and any Warrants issued in
substitution for or replacement of this Warrant, or any Warrants into which this
Warrant may be divided or exchanged.  The number and character of the
securities purchasable upon exercise of this Warrant and the Exercise Price are
subject to adjustment as provided below.

    

    This
Warrant may be assigned, transferred, sold, offered for sale, or exercised, in
whole or in part, by the Holder upon compliance with all the pertinent
provisions hereof.

    

    
      
        
           

        

        
          
          

          
            

          

        

        
           

        

      

    

    

    
      

      
        	
                
                  1.

                

              	
                 

              	Exercise of
      Warrant.

      

       

    

    
      	
               
      

            	
              (a)

            	
              Subject
      to the other terms and conditions of this Warrant, the purchase rights
      evidenced by this Warrant may be exercised in whole or in part at any
      time, and from time to time before the Expiration Date, by the Holder's
      presentation and surrender of this Warrant to the Company at its principal
      office or at the office of the Company's stock transfer agent, if any,
      accompanied by a duly executed Notice of Exercise, in the form attached to
      and by this reference incorporated in this Warrant as Exhibit A, and
      by payment of the aggregate Exercise Price, in immediately available
      funds, for that number of Warrant Securities specified in the Notice of
      Exercise.  In the event this Warrant is exercised in part only,
      as soon as is practicable after the presentation and surrender of this
      Warrant to the Company for exercise, the Company shall execute and deliver
      to the Holder a new Warrant, containing the same terms and conditions as
      this Warrant, evidencing the right of the Holder to purchase that number
      of Warrant Securities as to which this Warrant has not been
      exercised.

            

    

    

    
      	
               
      

            	
              (b) Upon receipt of this
      Warrant by the Company as described in subsection (a) above, the
      Holder shall be deemed to be the holder of record of the Warrant
      Securities issuable upon such exercise, notwithstanding that the transfer
      books of the Company may then be closed or that certificates representing
      such Warrant Securities may not have been prepared or actually delivered
      to the Holder.

            

    

     

    
      
        	
                
                  2.

                

              	
                 

              	Exchange,
      Assignment or Loss of Warrant.

      

       

    

    
      	
               
      

            	
              (a)

            	
              This
      Warrant may be sold, transferred or assigned at any time, in whole or in
      part, if (i) the transfer is by operation of law as a result of the
      death of any Holder to whom all or a portion of this Warrant may be
      transferred, (ii) the transfer is to any successor of the Holder's
      business and (iii) to such other persons for which transaction an
      exemption from the registration requirements of the Act can be established
      to the satisfaction of the Company.  All sales, transfers,
      assignments or hypothecations of this Warrant must be in compliance with
      Section 8 hereof.  Any assignment or transfer of this
      Warrant shall be made by the presentation and surrender of this Warrant to
      the Company at its principal office or the office of its transfer agent,
      if any, accompanied by a duly executed Assignment Form, in the form
      attached to and by this reference incorporated in this Warrant as
      Exhibit B.  Upon the presentation and surrender of these
      items to the Company, the Company, at its sole expense, shall execute and
      deliver to the new Holder or Holders a new Warrant or Warrants, containing
      the same terms and conditions as this Warrant, in the name of the new
      Holder or Holders as named in the Assignment Form, and this Warrant shall
      at that time be canceled.

            

    

    

    
      
        
           

        

        
          -
2 -

          
            

          

        

        
           

        

      

    

    

    

    
      	
               
      

            	
              (b)

            	
              This
      Warrant, alone or with other Warrants containing the same terms and
      conditions and owned by the same Holder, is exchangeable at the option of
      the Holder but at the Company's sole expense, at any time prior to its
      expiration either by its terms or by its exercise in full upon
      presentation and surrender to the Company at its principal office or at
      the office of its transfer agent, if any, for another Warrant or other
      Warrants, of different denominations but containing the same terms and
      conditions as this Warrant, entitling the Holder to purchase the same
      aggregate number of Warrant Securities that were purchasable pursuant to
      the Warrant or Warrants presented and surrendered.  At the time
      of presentation and surrender by the Holder to the Company, the Holder
      also shall deliver to the Company a written notice, signed by the Holder,
      specifying the denominations in which new Warrants are to be issued to the
      Holder.

            

    

    

    
      	
               
      

            	
              (c)

            	
              The
      Company will execute and deliver to the Holder a new Warrant containing
      the same terms and conditions as this Warrant upon receipt by the Company
      of evidence reasonably satisfactory to it of the loss, theft, destruction,
      or mutilation of this Warrant, provided that (i) in the case of loss,
      theft, or destruction, the Company receives from the Holder a reasonably
      satisfactory indemnification, and (ii) in the case of mutilation, the
      Holder presents and surrenders this Warrant to the Company for
      cancellation.  Any new Warrant executed and delivered shall
      constitute an additional contractual obligation on the part of the Company
      regardless of whether the Warrant that was lost, stolen, destroyed, or
      mutilated shall be enforceable by anyone at any
  time.

            

    

     

    
      
        
          	
                  
                    3.

                  

                	
                   

                	Anti-Dilution
      Provisions.

        

      

    

     

    
      
        	
                 
      

              	
                3.1

              	Stock Splits, Dividends,
      Etc.

      

       

    

    
      	
               
      

            	
              (a)

            	
              If
      the Company shall at any time subdivide its outstanding shares of Common
      Stock (or other securities at the time receivable upon the exercise of the
      Warrant) by recapitalization, reclassification or split-up thereof, or if
      the Company shall declare a stock dividend or distribute shares of Common
      Stock to its stockholders, the number of shares of Common Stock subject to
      this Warrant immediately prior to such subdivision shall be
      proportionately increased, and if the Company shall at any time combine
      the outstanding shares of Common Stock by recapitalization,
      reclassification or combination thereof, the number of shares of Common
      Stock subject to this Warrant immediately prior to such combination shall
      be proportionately decreased.  Any such adjustment and
      adjustment to the Exercise Price pursuant to this section shall be
      effective at the close of business on the effective date of such
      subdivision or combination or if any adjustment is the result of a stock
      dividend or distribution then the effective date for such adjustment based
      thereon shall be the record date
therefor.

            

    

    

    
      
        
           

        

        
          -
3 -

          
            

          

        

        
           

        

      

    

    

    

    
      	
               
      

            	
              (b)

            	
              Whenever
      the number of shares of Common Stock purchasable upon the exercise of this
      Warrant is adjusted, as provided in this section, the Exercise Price shall
      be adjusted to the nearest cent by multiplying such Exercise Price
      immediately prior to such adjustment by a fraction (x) the numerator of
      which shall be the number of shares of Common Stock purchasable upon the
      exercise immediately prior to such adjustment, and (y) the denominator of
      which shall be the number of shares of Common Stock so purchasable
      immediately thereafter.

            

    

    

    
      	
               
      

            	
              3.2

            	
              Adjustment for
      Reorganization, Consolidation, Merger, Etc.  In case of
      any reorganization of the Company (or any other corporation, the
      securities of which are at the time receivable on the exercise of this
      Warrant) shall consolidate with or merge into another corporation or
      convey all or substantially all of its assets to another corporation,
      then, and in each such case, the Holder of this Warrant upon the exercise
      at any time after the consummation of such reorganization, consolidation,
      merger or conveyance, shall be entitled to receive, in lieu of the
      securities and property receivable upon the exercise of this Warrant prior
      to such consummation, the securities or property to which such Holder
      would have been entitled upon such consummation if such Holder had
      exercised this Warrant immediately prior thereto; in each such case, the
      terms of this Warrant shall be applicable to the securities or property
      received upon the exercise of this Warrant after such
      consummation.

            

    

    

    
      	
               
      

            	
              3.3

            	
              Certificate as to
      Adjustments.  In each case of an adjustment in the number
      of shares of Common Stock receivable on the exercise of this Warrant, the
      Company at its expense shall promptly compute such adjustment in
      accordance with the terms of the Warrant and prepare a certificate
      executed by an officer of the Company setting forth such adjustment and
      showing the facts upon which such adjustment is based.  The
      Company shall forthwith mail a copy of each such certificate to each
      Holder.  The failure to prepare or provide such certificate
      shall not modify the rights of any party
  hereunder.

            

    

     

    
      
        	
                 
      

              	
                3.4

              	Notices of Record Date,
      Etc.  In case:

      

       

    

    
      	
               
      

            	
              (a)

            	
              the
      Company shall take a record of the holders of its Common Stock (or other
      securities at the time receivable upon the exercise of the Warrant) for
      the purpose of entitling them to receive any dividend (other than a cash
      dividend at the same rate as the rate of the last cash dividend
      theretofore paid) or other distribution, or any right to subscribe for,
      purchase or otherwise acquire any shares of stock of any class or any
      other securities, or to receive any other right;
  or

            

    

    

    
      
        
           

        

        
          -
4 -

          
            

          

        

        
           

        

      

    

    

    

    
      	
               
      

            	
              (b)

            	
              of
      any voluntary or involuntary dissolution, liquidation or winding-up of the
      Company, then, and in each such case, the Company shall mail or cause to
      be mailed to each Holder a notice specifying, as the case may be,
      (i) the date on which a record is to be taken for the purpose of such
      dividend, distribution or right, and stating the amount and character of
      such dividend, distribution or right, or (ii) the date on which such
      reorganization, reclassification, consolidation, merger, conveyance,
      dissolution, liquidation or winding-up is to take place, and the time, if
      any, to be fixed, as to which the holders of record of Common Stock (or
      such other securities at the time receivable upon the exercise of this
      Warrant) shall be entitled to exchange their shares of Common Stock (or
      such other securities) for securities or other property deliverable upon
      such reorganization, reclassification, consolidation, merger, conveyance,
      dissolution, liquidation or winding-up.  Such notice shall be
      mailed at least twenty (20) days prior to the date therein specified, and
      this Warrant may be exercised prior to said date during the term of the
      Warrant.

            

    

    

    
      	
               
      

            	
              3.5

            	
              Threshold for
      Adjustments.  Anything in this section to the contrary
      notwithstanding, the Company shall not be required to give effect to any
      adjustment until the cumulative resulting adjustment in the Exercise Price
      pursuant to Subsection 6.1.2 shall have required a change of the
      Exercise Price by at least $.01, but when the cumulative net effect of
      more than one adjustment so determined shall be to change the Exercise
      Price by at least $.01, such full change in the Exercise Price shall
      thereupon be given effect.  No adjustment shall be made by
      reason of the issuance of shares upon conversion rights, stock issuance
      rights or similar rights currently outstanding or any change in the number
      of treasury shares held by the
Company.

            

    

    

    
      	
              
                4.

              

            	
               

            	
              Reservation of Warrant
      Securities.  The Company hereby agrees that at all times
      prior to the Expiration Date, it will have authorized and will reserve and
      keep available for issuance and delivery to the Holder that number of
      Warrant Securities that may be required from time to time for issuance and
      delivery upon the exercise of the then unexercised portion of this Warrant
      and all other similar Warrants then outstanding and unexercised and upon
      the exercise of any Warrant
Securities.

            

    

    
      

      
        	
                
                  5.

                

              	
                 

              	Registration Under
      the Securities Act of 1933.

      

       

    

    
      	
               
      

            	
              (a)

            	
              If
      at any time prior to the Expiration Date, the Company files a registration
      statement with the United States Securities and Exchange Commission
      pursuant to the Securities Act of 1933, as amended (the "Act"), or
      pursuant to any other act passed after the date of this Agreement, which
      filing provides for the sale of securities by the Company to the public,
      or files a Regulation A Offering Statement under the Act, the Company
      shall offer to the Holder or Holders of this Warrant and the holders of
      any Warrant Securities the opportunity to register or qualify the Warrant
      (if prior to its expiration), Warrant Securities and any Warrant
      Securities underlying the unexercised portion of this Warrant, if any, at
      the Company's sole expense; provided, however, that in the case of a
      Regulation A offering, the opportunity to qualify shall be limited to
      the amount of the available exemption after taking into account the
      securities that the  Company wishes to
      qualify.  Notwithstanding anything to the contrary, this
      subsection (a) shall not be applicable to a registration statement on
      Forms S-4,
      S-8 or their successors or any other inappropriate forms filed by the
      Company with the United States Securities and Exchange
      Commission.

            

    

    

    
      
        
           

        

        
          -
5 -

          
            

          

        

        
           

        

      

    

    

     

    
       

      
        	
                 
      

              	
              	
                The
      Company shall deliver written notice to the Holder or Holders of this
      Warrant and to any holders of the Warrant Securities of its intention to
      file a registration statement or Regulation A Offering Statement
      under the Act at least 60 days prior to the filing of such registration
      statement or offering statement, and the Holder or Holders and holders of
      Warrant Securities shall have 30 days thereafter to request in writing
      that the Company register or qualify the Warrant, Warrant Securities, or
      the Warrant Securities underlying the unexercised portion of this Warrant
      in accordance with this subsection (a).  Upon the delivery
      of such a written request within the specified time, the Company shall be
      obligated to include in its contemplated registration statement or
      offering statement all information necessary or advisable to register or
      qualify the Warrant, Warrant Securities or Warrant Securities underlying
      the unexercised portion of this Warrant for a public offering, if the
      Company does file the contemplated registration statement or offering
      statement; provided, however, that neither the delivery of the notice by
      the Company nor the delivery of a request by a Holder or by a holder of
      Warrant Securities shall in any way obligate the Company to file a
      registration statement or offering statement.  Furthermore,
      notwithstanding the filing of a registration statement or offering
      statement, the Company may, at any time prior to the effective date
      thereof, determine not to offer the securities to which the registration
      statement or offering statement relates, other than the Warrant, Warrant
      Securities and Warrant Securities underlying the unexercised portion of
      this Warrant.

                

                The
      Company shall comply with the requirements of this subsection (a) and
      the related requirements of subsection (g) at its own
      expense.  That expense shall include, but not be limited to,
      legal, accounting, consulting, printing, federal and state filing fees,
      NASD fees, out-of-pocket expenses incurred by counsel, accountants and
      consultants retained by the Company, and miscellaneous expenses directly
      related to the registration statement or offering statement and the
      offering.  However, this expense shall not include the portion
      of any underwriting commissions, transfer taxes and the underwriter's
      accountable and nonaccountable expense allowances attributable to the
      offer and sale of the Warrant, Warrant Securities and the Warrant
      Securities underlying the unexercised portion of this Warrant, all of
      which expenses shall be borne by the Holder or Holders of this Warrant and
      the holders of the Warrant Securities registered or
    qualified.

              

      

       

    

    
      	
               
      

            	
              (b)

            	
              In
      the event that the Company registers or qualifies the Warrant, Warrant
      Securities or the Warrant Securities underlying the unexercised portion of
      this Warrant pursuant to subsection (a) above, the Company shall
      include in the registration statement or qualification, and the prospectus
      included therein, all information and materials necessary or advisable to
      comply with the applicable statutes and regulations so as to permit the
      public sale of the Warrant, Warrant Securities or the Warrant Securities
      underlying the unexercised portion of this Warrant.  As used in
      subsection (a) of this Section 7, reference to the Company's
      securities shall include, but not be limited to, any class or type of the
      Company's securities or the securities of any of the Company's
      subsidiaries or affiliates.

            

    

    

    
      
        
           

        

        
          -
6 -

          
            

          

        

        
           

        

      

    

    

    

    
      	
               
      

            	
              (c)

            	
              In
      addition to the registration rights described in subsection (a)
      above, the Company shall use its best efforts to register or qualify the
      Warrant and Warrant Securities within ninety (90) days of the date of this
      Warrant.  The Company shall deliver written notice to all
      Holders of this Warrant and holders of Warrant Securities, if any,
      advising them that the Company is proceeding with a registration statement
      or offering statement and that their Warrant and Warrant Securities will
      be included therein.  The Company will supply all information
      necessary or advisable for any such registration statements or offering
      statements at its own expense.

            

    

    

    
      	
               
      

            	
              (d)

            	
              As
      to each registration statement or offering statement, the Company's
      obligations contained in this Section 7 shall be conditioned upon a
      timely receipt by the Company in writing of the
  following:

            

    

    

    
      	
               
      

            	
              (i)

            	
              Information
      as to the terms of the contemplated public offering furnished by and on
      behalf of each Holder or holder intending to make a public distribution of
      the Warrant, Warrant Securities or Warrant Securities underlying the
      unexercised portion of the Warrant;
and

            

    

    

    
      	
               
      

            	
              (ii)

            	
              Such
      other information as the Company may reasonably require from such Holders
      or holders, or any underwriter for any of them, for inclusion in the
      registration statement or offering
statement.

            

    

    

    
      	
               
      

            	
              (e)

            	
              In
      each instance in which the Company shall take any action to register or
      qualify the Warrant, Warrant Securities or the Warrant Securities
      underlying the unexercised portion of this Warrant, if any, pursuant to
      this Section 7, the Company shall do the
  following:

            

    

    

    
      	
               
      

            	
              (i)

            	
              supply
      to Holder, or any successor or assign whose Warrant and Warrant Securities
      are being registered or qualified, two (2) manually signed copies of each
      registration statement or offering statement, and all amendments thereto,
      and a reasonable number of copies of the preliminary, final or other
      prospectus or offering circular, all prepared in conformity with the
      requirements of the Act and the rules and regulations promulgated
      thereunder, and such other documents as Holder shall reasonably
      request;

            

    

    

    
      	
               
      

            	
              (ii)

            	
              cooperate
      with respect to (A) all necessary or advisable actions relating to
      the preparation and the filing of any registration statements or offering
      statements, and all amendments thereto, arising from the provisions of
      this Section 7, (B) all reasonable efforts to establish an
      exemption from the provisions of the Act or any other federal or state
      securities statutes, (C) all necessary or advisable actions to
      register or qualify the public offering at issue pursuant to federal
      securities statutes and the state "blue sky" securities statutes of each
      jurisdiction that the Holders of the Warrant or holders of Warrant
      Securities shall reasonably request, and (D) all other necessary or
      advisable actions to enable the Holders of the Warrant and holders of the
      Warrant Securities to complete the contemplated disposition of their
      securities in each reasonably requested
  jurisdiction;

            

    

    

    
      
        
           

        

        
          -
7 -

          
            

          

        

        
           

        

      

    

    

    

    
      	
               
      

            	
              (iii)

            	
              keep
      all registration statements or offering statements to which this
      Section 7 applies, and all amendments thereto, effective under the
      Act for a period of at least nine (9) months after their initial
      effective date and cooperate with respect to all necessary or advisable
      actions to permit the completion of the public sale or other disposition
      of the securities subject to a registration statement or offering
      statement; and

            

    

    

    
      	
               
      

            	
              (iv)

            	
              indemnify
      and hold harmless each Holder of the Warrant, each holder of Warrant
      Securities, and each underwriter within the meaning of the Act for each
      such Holder or holder, from and against all losses, claims, damages, and
      liabilities, including, but not limited to, any and all expenses
      reasonably incurred in investigating, preparing, defending or settling any
      claim, arising from or relating to (A) any untrue or alleged untrue
      statement of a material fact contained in any registration statement or
      offering statement to which this Section 7 applies, or (B) any
      omission or alleged omission to state a material fact necessary to make
      the statements contained in a registration statement or offering statement
      to which this Section 7 applies not misleading; provided, however,
      that the indemnification contained in this provision (iv) shall not
      apply if the untrue statement or omission, or alleged untrue statement or
      omission, was the result of information furnished in writing to the
      Company by the Holder, holder or underwriter seeking indemnification
      expressly for use in the registration statement or offering statement at
      issue.  To the extent that the indemnification contained in this
      provision applies, the Company also shall indemnify and hold harmless each
      officer, director, employee, controlling person or agent of an indemnified
      Holder, holder or underwriter.

            

    

    

    
      	
               
      

            	
              (f)

            	
              In
      each instance in which pursuant to this Section 7 the Company shall
      take any action to register or qualify the Warrant, Warrant Securities or
      the Warrant Securities underlying the unexercised portion of this Warrant,
      prior to the effective date of any registration statement or offering
      statement, the Company and each Holder or holder of Warrants or Warrant
      Securities being registered or qualified shall enter into reciprocal
      indemnification agreements, in the form customarily used by reputable
      investment bankers with respect to public offerings of securities,
      containing substantially the same terms as described in
      subsection (e)(iv) above.  These indemnification agreements
      also shall contain an agreement by the Holder or shareholder at issue to
      indemnify and hold harmless the Company, its officers, directors from and
      against any and all losses, claims, damages and liabilities, including,
      but not limited to, all expenses reasonably incurred in investigating,
      preparing, defending or settling any claim, directly resulting from any
      untrue statements of material facts, or omissions to state a material fact
      necessary to make a statement not misleading, contained in a registration
      statement or offering statement to which this Section 7 applies, if,
      and only if, the untrue statement or omission directly resulted from
      information provided in writing to the Company by the indemnifying Holder
      or shareholder expressly for use in the registration statement or offering
      statement at issue.

            

    

    

    
      
        
           

        

        
          -
8 -

          
            

          

        

        
           

        

      

    

    

    

    

    
      	
               
      

            	
              (g)

            	
              The
      term "Majority Holder" as used in this Section 7 shall include any
      Holder, any holder of Warrant Securities, or any combination of Holders
      and such holders of Warrant Securities, if they hold, in the aggregate,
      unexercised Warrants plus issued and outstanding Warrant Securities equal
      to more than 50% of the total of (i) all Warrant Securities issued
      and outstanding as a result of the exercise of the Warrant, and
      (ii) all Warrant Securities that may at that time be purchased by
      exercising the unexercised portion of the Warrant.  For purposes
      hereof, a Warrant entitling the Holder to purchase more than one Warrant
      Security shall be deemed to hold Warrants equal to the number of Warrant
      Securities which may be acquired pursuant to any such
    Warrant.

            

    

    

    
      	
               
      

            	
              (h)

            	
              The
      Company's obligations described in this Section 7 shall continue in
      full force and effect regardless of the exercise, surrender, cancellation
      or expiration of this Warrant.

            

    

    

    
      	
               
      

            	
              (i)

            	
              The
      registration rights provided under this Section 7 shall not be applicable
      to an initial public offering of the Company’s Common Stock, nor for a
      period of six (6) months following the initial public offering of the
      Company’s Common Stock.

            

    

    

    
      	
              6.  

            	
              Maximum
      Exercise.  The Holder shall not be entitled to exercise
      this Warrant on an exercise date nor may the Company exercise its right to
      give a “Call Notice” (as defined in Section 7) in connection with that
      number of shares of Common Stock which would be in excess of the sum
      of:  (i) the number of shares of Common Stock beneficially
      owned by the Holder and its Affiliates on an exercise date or Call Date;
      and (ii) the number of shares of Common Stock issuable upon the
      exercise of this Warrant with respect to which the determination of this
      limitation is being made on an exercise date or Call Date, which would
      result in beneficial ownership by the Holder and its Affiliates of more
      than 9.99% of the outstanding Common Stock on such date.  For
      the purposes of the immediately preceding sentence, beneficial ownership
      shall be determined in accordance with Section 13(d) of the
      Securities Exchange Act of 1934, as amended, and Regulation 13d-3
      thereunder.  Subject to the foregoing, the Holder shall not be
      limited to aggregate exercises which would result in the issuance of more
      than 9.99%.  The restriction described in this Section may
      be waived, in whole or in part, upon sixty-one (61) days prior notice from
      the Holder to the Company.  The Holder may allocate which of the
      equity of the Company deemed beneficially owned by the Subscriber shall be
      included in the 9.99% amount described above and which shall be allocated
      to the excess above 9.99%.

            

    

    

    
      	
              
                7.

              

            	
               

            	
              Call.   The
      Company shall have the option to "call" the exercise of the Warrant from
      time to time, in accordance with and governed by the
      following:

            

    

     

    
      	
               
      

            	
              (a)

            	
              The
      Company shall exercise the Warrant Call by giving to the Holder a notice
      of call upon twenty (20) days written notice (the "Call Notice") during
      the period in which the Warrant Call may be exercised.  The
      effective date of each Call Notice (the “Call Date”) is the date on which
      notice is effective under the notice provision of Section 13 of this
      Warrant.

            

    

     

    

    
      
        
           

        

        
          -
9 -

          
            

          

        

        
           

        

      

    

    

    

     

    
      	
               
      

            	
              (b)

            	
              The
      Company's right to exercise the Warrant Call shall commence twenty (20)
      Trading Days after the actual effective date of a Registration Statement
      and end twenty (20) days prior to the Expiration
  Date.

            

    

     

    
      	
               
      

            	
              (c)

            	
              The
      number of shares of Common Stock to be issued upon exercise of the
      Warrants which are subject to a Call Notice must be registered in a
      Registration Statement effective from thirty (30) Business Days prior to
      the Call Date and through the date such Common Stock is actually delivered
      to the Warrant Holder (the “Delivery
Date”).

            

    

     

    
      	
               
      

            	
              (d)

            	
              A
      Call Notice may be given by the Company only within ten (10) days after
      the Common Stock has had a closing price as reported for the Principal
      Market (as defined below) of not less than $2.50 per share for twenty out
      of thirty consecutive Trading Days (the “Lookback Period”) with trading
      volume in excess of 50,000 shares per
day.

            

    

    

    
      	
               
      

            	
              (e)

            	
              For
      purposes hereof, the Principal Market for the Company shall be as
      follows:  If the Company's Common Stock is traded on an exchange
      or is quoted on Nasdaq Global Select Market, Nasdaq Global Market, Nasdaq
      Capital Market or the American Stock Exchange, LLC, then such exchange
      shall be the Principal Market.  If the Company's Common Stock is
      not traded on an exchange, but is traded in the over-the-counter market,
      then that shall be the Principal
Market.

            

    

     

    
      
        	
                 
      

              	
                (f)

              	
                The
      Common Stock must be listed on the Principal Market for the Lookback
      Period and through the Delivery
Date.

              

      

       

    

    
      	
               
      

            	
              (g)

            	
              The
      Holder shall exercise his Warrant rights and purchase the Called Warrant
      Shares and pay for same within twenty (20) days after the Call
      Date.  If the Holder fails to timely pay the amount required by
      the Warrant Call, the Company’s sole remedy shall be to cancel a
      corresponding amount of the Holder’s
Warrants.

            

    

     

    
      	
               
      

            	
              (h)

            	
              In
      no event shall a Call Notice be given in connection with the exercise of
      an amount of Common Stock which would cause the Holder to exceed the
      limitation amount set forth in Section
6.

            

    

     

    
      
        	
                
                  8.

                

              	
                 

              	Transfer to Comply
      With the Securities Act of 1933.

      

       

    

    
      	
               
      

            	
              (a)

            	
              This
      Warrant, the Warrant Securities, and all other securities issued or
      issuable upon exercise of this Warrant, may not be offered, sold or
      transferred, in whole or in part, except in compliance with the Act, and
      except in compliance with all applicable state securities
      statutes.

            

    

    

    
      	
               
      

            	
              (b)

            	
              The
      Company may cause the following legend, or its equivalent, to be set forth
      on each certificate representing the Warrant Securities, or any other
      security issued or issuable upon exercise of this Warrant, not theretofore
      distributed to the public or sold to underwriters, as defined by the Act,
      for distribution to the public pursuant to Section 7
      above:

            

    

    

    
      
        
           

        

        
          -
10 -

          
            

          

        

        
           

        

      

    

    

    

    

    
      	
               
      

            	
              "The
      securities represented by this Certificate have not been registered under
      the Securities Act of 1933 ("the Act") and are 'restricted securities' as
      that term is defined in Rule 144 under the Act.  The
      securities may not be offered for sale, sold or otherwise transferred
      except pursuant to an effective registration statement under the Act or
      pursuant to an exemption from registration under the Act, the availability
      of which is to be established to the satisfaction of the
      Company."

            

    

    

    
      	
              
                9.

              

            	
            	
              Fractional
      Shares.  No fractional shares or scrip representing
      fractional shares shall be issued upon the exercise of all or any part of
      this Warrant.  With respect to any fraction of a share of any
      security called for upon any exercise of this Warrant, the Company shall
      pay to the Holder an amount in money equal to that fraction multiplied by
      the current market value of that share.  The current market
      value shall be determined as
follows:

            

    

    

    
      	
               
      

            	
              (i)

            	
              if
      the security at issue is listed on a national securities exchange or
      admitted to unlisted trading privileges on such an exchange or listed on
      the National Association of Securities Dealers National Market System, the
      current value shall be the last reported sale price of that security on
      such exchange or system on the last business day prior to the date of the
      applicable exercise of this Warrant or, if no such sale is made on such
      day, the average of the highest closing bid and lowest asked price for
      such day on such exchange or system;
or

            

    

    

    
      	
               
      

            	
              (ii)

            	
              if
      the security at issue is not so listed or admitted to unlisted trading
      privileges, the current market value shall be the average of the last
      reported highest bid and lowest asked prices quoted on the National
      Association of Securities Dealers Automated Quotations System or, if not
      so quoted, then by the National Quotation Bureau, Inc. on the last
      business day prior to the day of the applicable exercise of this Warrant;
      or

            

    

    

    
      	
               
      

            	
              (iii)

            	
              if
      the security at issue is not so listed or admitted to unlisted trading
      privileges and bid and asked prices are not reported, the current market
      value shall be determined in such reasonable manner as may be prescribed
      from time to time by the Board of Directors of the Company, subject to the
      arbitration procedure as described in Section 15 below if a Holder
      delivers written notice to the Company of an objection within thirty (30)
      days after the Board’s decision.

            

    

    

    
      	
              10.

            	
              Rights of the
      Holder.  The Holder shall not be entitled to any rights
      as a shareholder in the Company by reason of this Warrant, either at law
      or equity, except as specifically provided for herein.  The
      Company covenants, however, that for so long as this Warrant is at least
      partially unexercised, it will furnish any Holder of this Warrant with
      copies of all reports and communications furnished to the shareholders of
      the Company.

            

    

    

    
      	
              11.

            	
              Charges Due Upon
      Exercise.  The Company shall pay any and all issue or
      transfer taxes, including, but not limited to, all federal or state taxes,
      that may be payable with respect to the transfer of this Warrant or the
      issue or delivery of Warrant Securities upon the exercise of this
      Warrant.

            

    

    

    
      
        
           

        

        
          -
11 -

          
            

          

        

        
           

        

      

    

    

    

    

    
      	
              12.

            	
              Warrant Securities to
      be Fully Paid.  The Company covenants that all Warrant
      Securities that may be issued and delivered to a Holder of this Warrant
      upon the exercise of this Warrant will be, upon such delivery, validly and
      duly issued, fully paid and
nonassessable.

            

    

    

    
      	
              13.

            	
              Notices.  All
      notices, certificates, requests, or other similar items provided for in
      this Warrant shall be in writing and shall be personally delivered or
      deposited in the United States mail, postage prepaid, addressed to the
      respective party as indicated in the portions of this Warrant preceding
      Section 1.  All notices shall be deemed to be delivered
      upon personal delivery or upon the expiration of three (3) business days
      following deposit in the United States mail, postage
      prepaid.  The addresses of the parties may be changed, and
      addresses of other Holders and holders of Warrant Securities may be
      specified, by written notice delivered pursuant to this
      Section 13.  The Company's principal office shall be deemed
      to be the address provided pursuant to this Section for the delivery of
      notices to the Company.

            

    

    

    
      	
              14.

            	
              Applicable
      Law.  This Warrant shall be governed by and construed in
      accordance with the laws of the State of Colorado, and courts located in
      Colorado shall have exclusive jurisdiction over all disputes arising
      hereunder except as provided in Section 15
  hereof.

            

    

    

    
      
        	
                15.

              	
                

                  Dispute
      Resolution.  The parties shall attempt in good faith to
      resolve any controversy or claim arising out of or relating to this
      Warrant, or the breach, termination, or validity thereof (a “Dispute”)
      promptly by negotiation between the parties.  If a Dispute has
      not been resolved within thirty (30) days by negotiation, the parties
      shall attempt to mediate the Dispute through the selection of a mutually
      agreeable mediator who shall conduct such mediation in
      confidence.  If a Dispute is not resolved by mediation, then the
      Dispute shall be settled by arbitration in accordance with the Commercial
      Arbitration Rules of the American Arbitration Association, and governed by
      the United States Arbitration Act, 9 U.S.C. §§ 1-16, except as otherwise
      provided herein.  Judgment upon the award rendered by the
      arbitrator may be entered by any court having jurisdiction
      thereof.  The place of arbitration shall be Denver,
      Colorado.  Each party shall be responsible for his own attorney
      fees incurred during any phase of dispute resolution.  The
      arbitrator shall apply the law to the dispute in the same manner as a
      judge as though the dispute was before a court of law of the State of
      Colorado.  The arbitrator shall have the authority to award any
      remedy or relief that a court of the State of Colorado could order or
      grant, including, without limitation, specific performance of any
      obligation created under the Agreement, the issuance of an injunction, or
      the imposition of sanctions for abuse or frustration of the arbitration
      process.  Notwithstanding the foregoing, the arbitrator shall
      not have authority to award punitive damages.  The parties shall
      take all reasonable steps necessary to conduct a hearing no later than
      forty-five (45) days after submission of the matter to
      arbitration.  The arbitrator shall render his decision within
      fifteen (15) days after the close of the arbitration
      hearing.  The arbitration award shall be in writing and shall
      specify the factual and legal bases for the
  award.

                

              

      

    

    

    
      
        
           

        

        
          -
12 -

          
            

          

        

        
           

        

      

    

    

    
      

      
        	
                
                  16.

                

              	
                 

              	Miscellaneous
      Provisions.

      

       

    

    
      	
               
      

            	
              (a)

            	
              Subject
      to the terms and conditions contained herein, this Warrant shall be
      binding on the Company and its successors and shall inure to the benefit
      of the original Holder, its successors and assigns and all holders of
      Warrant Securities and the exercise of this Warrant in full shall not
      terminate the provisions of this Warrant as it relates to holders of
      Warrant Securities.

            

    

    

    
      	
               
      

            	
              (b)

            	
              If
      the Company fails to perform any of its obligations hereunder, it shall be
      liable to the Holder for all damages, costs and expenses resulting from
      the failure, including, but not limited to, all reasonable attorney's fees
      and disbursements.

            

    

    

    
      	
               
      

            	
              (c)

            	
              This
      Warrant cannot be changed or terminated or any performance or condition
      waived in whole or in part except by an agreement in writing signed by the
      party against whom enforcement of the change, termination or waiver is
      sought.

            

    

    

    
      	
               
      

            	
              (d)

            	
              If
      any provision of this Warrant shall be held to be invalid, illegal or
      unenforceable, such provision shall be severed, enforced to the extent
      possible, or modified in such a way as to make it enforceable, and the
      invalidity, illegality or unenforceability shall not affect the remainder
      of this Warrant.

            

    

    

    
      	
               
      

            	
              (e)

            	
              The
      Company agrees to execute such further agreements, conveyances,
      certificates and other documents as may be reasonably requested by the
      Holder to effectuate the intent and provisions of this
      Warrant.

            

    

    

    
      	
               
      

            	
              (f)

            	
              Paragraph
      headings used in this Warrant are for convenience only and shall not be
      taken or construed to define or limit any of the terms or provisions of
      this Warrant.  Unless otherwise provided, or unless the context
      shall otherwise require, the use of the singular shall include the plural
      and the use of any gender shall include all
  genders.

            

    

     

    
      
        
          
            
              	 	  

                      ATTEST:

                    	 	 OMNI BIO PHARMACEUTICAL, INC.
	 	 	 	 
	
                        By   

                    	____________________________________	
                       By    

                    	____________________________________ 
	 	Bob
      Ogden   	 	
                      Edward
      Larkin

                    
	 	
                      Secretary

                    	 	
                      Chief
      Operating Officer

                    
	 	 	 	 

            

          

        

      

    

     

    

    
      
        
           

        

        
          -
13 -

          
            

          

        

        
           

        

      

    

    

    EXHIBIT
A

    

    NOTICE
OF EXERCISE

    

    (To be
executed by a Holder desiring to exercise the right to purchase Shares pursuant
to a Warrant.)

    

    
      The undersigned Holder of a Warrant
hereby

      

      
        	
                (a)

              	
                irrevocably
      elects to exercise the Warrant to the extent of purchasing _______________
      Shares;

              

      

      

      
        
          
            	
                    (b)

                  	
                    makes
      payment in full of the aggregate Exercise Price for those Shares in the
      amount of $ ___________ by
      the delivery of immediately available funds in the amount of $ ________
      ;

                  

          

        

      

      

      
        	
                (c)

              	
                requests
      that certificates evidencing the securities underlying such Shares be
      issued in the name of the undersigned, or, if the name and address of some
      other person is specified below, in the name of such other
      person:

              

      

      

       
__________________________________________________

    

    __________________________________________________

    

    __________________________________________________

    (Name and
address of person other than
the

    undersigned
in whose name Shares are to be registered)

    

    
      	
              (d)

            	
              requests,
      if the number of Shares purchased are not all the Shares purchasable
      pursuant to the unexercised portion of the Warrant, that a new Warrant of
      like tenor for the remaining Shares purchasable pursuant to the Warrant be
      issued and delivered to the undersigned at the address stated
      below.

            

    

     

    

     

    
      	
              Dated:
      _______________________

            	 
      	 
      
	 
      	 
      	
              Signature
      ______________________________________

            
	 
      	 
      	
              (This
      signature must conform in all respects

              to
      the name of the Holder as specified on the

              face
      of the Warrant.)

            
	 
      	 
      	 
      
	
               ____________________________________

            	 
      	 
      
	
              Social
      Security Number or Employer ID Number

            	 
      	
               _____________________________________

            
	 
      	 
      	
              Printed
      Name

            
	 
      	 
      	 
      
	 
      	
               Address:    

            	
              _____________________________________

               

              _____________________________________

            

    

    

    

    
      
        
           

        

        
          -
14 -

          
            

          

        

        
           

        

      

    

    

    

    EXHIBIT
B

    

    ASSIGNMENT
FORM

    

    

    FOR VALUE
RECEIVED, the undersigned,, hereby sells, assigns and transfers
unto:

    

    Name:    ______________________________________________________

    (Please type or print in block
letters)

    

    Address: ______________________________________________________

    
 

    

    the right
to purchase  ____________ Shares of Omni Bio Pharmaceutical, Inc. (the
"Company") pursuant to the terms and conditions of the Warrant held by the
undersigned.  The undersigned hereby authorizes and directs the
Company (i) to issue and deliver to the above-named assignee at the above
address a new Warrant pursuant to which the rights to purchase being assigned
may be exercised, and (ii) if there are rights to purchase Shares remaining
pursuant to the undersigned's Warrant after the assignment contemplated herein,
to issue and deliver to the undersigned at the address stated below a new
Warrant evidencing the right to purchase the number of Shares remaining after
issuance and delivery of the Warrant to the above-named
assignee.  Except for the number of Shares purchasable, the new
Warrants to be issued and delivered by the Company are to contain the same terms
and conditions as the undersigned's Warrant.  To complete the
assignment contemplated by this Assignment Form, the undersigned hereby
irrevocably constitutes and
appoints ____________________________________ as the undersigned's
attorney-in-fact to transfer the Warrants and the rights thereunder on the books
of the Company with full power of substitution for these purposes.

    

    

     

    
      	
              Dated:
      _______________________________

            	 
      	 
      
	 
      	 
      	
              Signature
      _____________________________________

            
	 
      	 
      	
              (This
      signature must conform in all respects

              to
      the name of the Holder as specified on the

              face
      of the Warrant.)

            
	 
      	 
      	 
      
	
               ____________________________________

            	 
      	 
      
	
              Social
      Security Number or Employer ID Number

            	 
      	
              _____________________________________

            
	 
      	 
      	
              Printed
      Name

            
	 
      	 
      	 
      
	 
      	
               Address:    

            	
              _____________________________________

               

              _____________________________________

            

    

    

    

    - 15 -omnibio10k_ex1562709.htm

    
 

    Exhibit
10.15

    

    FORM
OF INVESTOR WARRANT

    

    WARRANT
NO.__

    

    WARRANT
TO PURCHASE SHARES

    OF
COMMON STOCK OF

    Across
America Financial Services, Inc

    (pending
name change to Omni Bio Pharmaceutical, Inc.)

    

    Warrant
to Purchase _____ Shares

    (subject
to adjustment as set forth herein)

    

    Exercise
Price $1.00 Per Share

    (subject
to adjustment as set forth herein)

    

    VOID
AFTER 5 P.M., MST, TIME, March 31, 2014

    

    THE
SECURITIES REPRESENTED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE "ACT") OR REGISTERED OR QUALIFIED UNDER
ANY OTHER APPLICABLE FEDERAL OR STATE SECURITIES LAWS.  THESE
SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, OR OTHERWISE TRANSFERRED, IN WHOLE
OR IN PART, EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR
QUALIFICATION FILED IN ACCORDANCE WITH THE ACT OR PURSUANT TO AN EXEMPTION FROM
REGISTRATION UNDER THE ACT.

    

    Across
America Financial Services, Inc. (whose name is being changed to Omni Bio
Pharmaceutical, Inc.), 5350 S. Roslyn St., Suite 400, Greenwood Village,
Colorado 80111 (the "Company"), hereby certifies that, for value received,
«Name», «Address», «City_», «State_», «Zip» (who, together with any subsequent
holder of the Warrant, is referred to as the "Holder"), is entitled, subject to
the terms and conditions set forth below, to purchase from the Company at any
time before 5 p.m., MST time, on March 31, 2014 ("Expiration Date")(five
years from date of issue), up to «Amount_100» shares of the Company's $.001 par
value Common Stock (the "Shares") at a purchase price of $1.00 per Share (the
"Exercise Price").

    

    The term
"Warrant" as used herein shall include this Warrant and any Warrants issued in
substitution for or replacement of this Warrant, or any Warrants into which this
Warrant may be divided or exchanged.  The number and character of the
securities purchasable upon exercise of this Warrant and the Exercise Price are
subject to adjustment as provided below.

    

    This
Warrant may be assigned, transferred, sold, offered for sale, or exercised, in
whole or in part, by the Holder upon compliance with all the pertinent
provisions hereof.

    

    
      
        
           

        

        
          
          

          
            

          

        

        
           

        

      

    

     

    
      

      
        	
                
                  1.

                

              	
              	Exercise of
      Warrant.

      

    

    

    
      	
               
      

            	
              (a)

            	
              Subject
      to the other terms and conditions of this Warrant, the purchase rights
      evidenced by this Warrant may be exercised in whole or in part at any
      time, and from time to time before the Expiration Date, by the Holder's
      presentation and surrender of this Warrant to the Company at its principal
      office or at the office of the Company's stock transfer agent, if any,
      accompanied by a duly executed Notice of Exercise, in the form attached to
      and by this reference incorporated in this Warrant as Exhibit A, and
      by payment of the aggregate Exercise Price, in immediately available
      funds, for that number of Warrant Securities specified in the Notice of
      Exercise.  In the event this Warrant is exercised in part only,
      as soon as is practicable after the presentation and surrender of this
      Warrant to the Company for exercise, the Company shall execute and deliver
      to the Holder a new Warrant, containing the same terms and conditions as
      this Warrant, evidencing the right of the Holder to purchase that number
      of Warrant Securities as to which this Warrant has not been
      exercised.

            

    

    
      

      
        	
                 
      

              	
                (b)

              	Upon receipt of this Warrant by the Company as described in
      subsection (a) above, the Holder shall be deemed to be the holder of
      record of the Warrant Securities issuable upon such exercise,
      notwithstanding that the transfer books of the Company may then be closed
      or that certificates representing such Warrant Securities may not have
      been prepared or actually delivered to the
Holder.

      

       

    

    
      
        
          	
                  
                    2.

                  

                	
                	Exchange,
      Assignment or Loss of Warrant.

        

         

      

    

    
      	
               
      

            	
              (a)

            	
              This
      Warrant may be sold, transferred or assigned at any time, in whole or in
      part, if (i) the transfer is by operation of law as a result of the
      death of any Holder to whom all or a portion of this Warrant may be
      transferred, (ii) the transfer is to any successor of the Holder's
      business and (iii) to such other persons for which transaction an
      exemption from the registration requirements of the Act can be established
      to the satisfaction of the Company.  All sales, transfers,
      assignments or hypothecations of this Warrant must be in compliance with
      Section 8 hereof.  Any assignment or transfer of this
      Warrant shall be made by the presentation and surrender of this Warrant to
      the Company at its principal office or the office of its transfer agent,
      if any, accompanied by a duly executed Assignment Form, in the form
      attached to and by this reference incorporated in this Warrant as
      Exhibit B.  Upon the presentation and surrender of these
      items to the Company, the Company, at its sole expense, shall execute and
      deliver to the new Holder or Holders a new Warrant or Warrants, containing
      the same terms and conditions as this Warrant, in the name of the new
      Holder or Holders as named in the Assignment Form, and this Warrant shall
      at that time be canceled.

            

    

    

    
      	
               
      

            	
              (b)

            	
              This
      Warrant, alone or with other Warrants containing the same terms and
      conditions and owned by the same Holder, is exchangeable at the option of
      the Holder but at the Company's sole expense, at any time prior to its
      expiration either by its terms or by its exercise in full upon
      presentation and surrender to the Company at its principal office or at
      the office of its transfer agent, if any, for another Warrant or other
      Warrants, of different denominations but containing the same terms and
      conditions as this Warrant, entitling the Holder to purchase the same
      aggregate number of Warrant Securities that were purchasable pursuant to
      the Warrant or Warrants presented and surrendered.  At the time
      of presentation and surrender by the Holder to the Company, the Holder
      also shall deliver to the Company a written notice, signed
      by the Holder, specifying the denominations in which new Warrants are to
      be issued to the Holder.

            

    

    

    
      
        
           

        

        
          -
2 -

          
            

          

        

        
           

        

      

    

    
 

    

    
      	
               
      

            	
              (c)

            	
              The
      Company will execute and deliver to the Holder a new Warrant containing
      the same terms and conditions as this Warrant upon receipt by the Company
      of evidence reasonably satisfactory to it of the loss, theft, destruction,
      or mutilation of this Warrant, provided that (i) in the case of loss,
      theft, or destruction, the Company receives from the Holder a reasonably
      satisfactory indemnification, and (ii) in the case of mutilation, the
      Holder presents and surrenders this Warrant to the Company for
      cancellation.  Any new Warrant executed and delivered shall
      constitute an additional contractual obligation on the part of the Company
      regardless of whether the Warrant that was lost, stolen, destroyed, or
      mutilated shall be enforceable by anyone at any
  time.

            

    

     

    
      
        
          	
                  
                    3.

                  

                	
                	Anti-Dilution
      Provisions.

        

      

       

      
        
          	
                   
      

                	
                  3.1

                	Stock Splits, Dividends,
      Etc.

        

      

    

    

    
      	
               
      

            	
              (a)

            	
              If
      the Company shall at any time subdivide its outstanding shares of Common
      Stock (or other securities at the time receivable upon the exercise of the
      Warrant) by recapitalization, reclassification or split-up thereof, or if
      the Company shall declare a stock dividend or distribute shares of Common
      Stock to its stockholders, the number of shares of Common Stock subject to
      this Warrant immediately prior to such subdivision shall be
      proportionately increased, and if the Company shall at any time combine
      the outstanding shares of Common Stock by recapitalization,
      reclassification or combination thereof, the number of shares of Common
      Stock subject to this Warrant immediately prior to such combination shall
      be proportionately decreased.  Any such adjustment and
      adjustment to the Exercise Price pursuant to this section shall be
      effective at the close of business on the effective date of such
      subdivision or combination or if any adjustment is the result of a stock
      dividend or distribution then the effective date for such adjustment based
      thereon shall be the record date
therefor.

            

    

    

    
      	
               
      

            	
              (b)

            	
              Whenever
      the number of shares of Common Stock purchasable upon the exercise of this
      Warrant is adjusted, as provided in this section, the Exercise Price shall
      be adjusted to the nearest cent by multiplying such Exercise Price
      immediately prior to such adjustment by a fraction (x) the numerator of
      which shall be the number of shares of Common Stock purchasable upon the
      exercise immediately prior to such adjustment, and (y) the denominator of
      which shall be the number of shares of Common Stock so purchasable
      immediately thereafter.

            

    

    

    
      
        
           

        

        
          -
3 -

          
            

          

        

        
           

        

      

    

    

    

    
      	
               
      

            	
              3.2

            	
              Adjustment for
      Reorganization, Consolidation, Merger, Etc.  In case of
      any reorganization of the Company (or any other corporation, the
      securities of which are at the time receivable on the exercise of this
      Warrant) shall consolidate with or merge into another corporation or
      convey all or substantially all of its assets to another corporation,
      then, and in each such case, the Holder of this Warrant upon the exercise
      at any time after the consummation of such reorganization, consolidation,
      merger or conveyance, shall be entitled to receive, in lieu of the
      securities and property receivable upon the exercise of this Warrant prior
      to such consummation, the securities or property to which such Holder
      would have been entitled upon such consummation if such Holder had
      exercised this Warrant immediately prior thereto; in each such case, the
      terms of this Warrant shall be applicable to the securities or property
      received upon the exercise of this Warrant after such
      consummation.

            

    

    

    
      	
               
      

            	
              3.3

            	
              Certificate as to
      Adjustments.  In each case of an adjustment in the number
      of shares of Common Stock receivable on the exercise of this Warrant, the
      Company at its expense shall promptly compute such adjustment in
      accordance with the terms of the Warrant and prepare a certificate
      executed by an officer of the Company setting forth such adjustment and
      showing the facts upon which such adjustment is based.  The
      Company shall forthwith mail a copy of each such certificate to each
      Holder.  The failure to prepare or provide such certificate
      shall not modify the rights of any party
  hereunder.

            

    

     

    
      
        	
                 
      

              	
                3.4

              	Notices of Record Date, Etc.  In
case:

      

       

    

    
      	
               
      

            	
              (a)

            	
              the
      Company shall take a record of the holders of its Common Stock (or other
      securities at the time receivable upon the exercise of the Warrant) for
      the purpose of entitling them to receive any dividend (other than a cash
      dividend at the same rate as the rate of the last cash dividend
      theretofore paid) or other distribution, or any right to subscribe for,
      purchase or otherwise acquire any shares of stock of any class or any
      other securities, or to receive any other right;
  or

            

    

    

    
      	
               
      

            	
              (b)

            	
              of
      any voluntary or involuntary dissolution, liquidation or winding-up of the
      Company, then, and in each such case, the Company shall mail or cause to
      be mailed to each Holder a notice specifying, as the case may be,
      (i) the date on which a record is to be taken for the purpose of such
      dividend, distribution or right, and stating the amount and character of
      such dividend, distribution or right, or (ii) the date on which such
      reorganization, reclassification, consolidation, merger, conveyance,
      dissolution, liquidation or winding-up is to take place, and the time, if
      any, to be fixed, as to which the holders of record of Common Stock (or
      such other securities at the time receivable upon the exercise of this
      Warrant) shall be entitled to exchange their shares of Common Stock (or
      such other securities) for securities or other property deliverable upon
      such reorganization, reclassification, consolidation, merger, conveyance,
      dissolution, liquidation or winding-up.  Such notice shall be
      mailed at least twenty (20) days prior to the date therein specified, and
      this Warrant may be exercised prior to said date during the term of the
      Warrant.

            

    

    

    
      
        
           

        

        
          -
4 -

          
            

          

        

        
           

        

      

    

     

    
      

      
        	
                 
      

              	
                3.5

              	Threshold for Adjustments.  Anything in this section to the
      contrary notwithstanding, the Company shall not be required to give effect
      to any adjustment until the cumulative resulting adjustment in the
      Exercise Price pursuant to Subsection 6.1.2 shall have required a
      change of the Exercise Price by at least $.01, but when the cumulative net
      effect of more than one adjustment so determined shall be to change the
      Exercise Price by at least $.01, such full change in the Exercise Price
      shall thereupon be given effect.  No adjustment shall be made by
      reason of the issuance of shares upon conversion rights, stock issuance
      rights or similar rights currently outstanding or any change in the number
      of treasury shares held by the Company.

      

    

    

    
      	
              
                4.

              

            	
               

            	
              Reservation of Warrant
      Securities.  The Company hereby agrees that at all times
      prior to the Expiration Date, it will have authorized and will reserve and
      keep available for issuance and delivery to the Holder that number of
      Warrant Securities that may be required from time to time for issuance and
      delivery upon the exercise of the then unexercised portion of this Warrant
      and all other similar Warrants then outstanding and unexercised and upon
      the exercise of any Warrant
Securities.

            

    

    
      

      
        	
                
                  5.

                

              	
                 

              	Registration Under
      the Securities Act of 1933.

      

       

    

    
      	
               
      

            	
              (a)

            	
              If
      at any time prior to the Expiration Date, the Company files a registration
      statement with the United States Securities and Exchange Commission
      pursuant to the Securities Act of 1933, as amended (the "Act"), or
      pursuant to any other act passed after the date of this Agreement, which
      filing provides for the sale of securities by the Company to the public,
      or files a Regulation A Offering Statement under the Act, the Company
      shall offer to the Holder or Holders of this Warrant and the holders of
      any Warrant Securities the opportunity to register or qualify the Warrant
      (if prior to its expiration), Warrant Securities and any Warrant
      Securities underlying the unexercised portion of this Warrant, if any, at
      the Company's sole expense; provided, however, that in the case of a
      Regulation A offering, the opportunity to qualify shall be limited to
      the amount of the available exemption after taking into account the
      securities that the  Company wishes to
      qualify.  Notwithstanding anything to the contrary, this
      subsection (a) shall not be applicable to a registration statement on
      Forms S-4, S-8 or their successors or any other inappropriate forms
      filed by the Company with the United States Securities and Exchange
      Commission.

            

    

    

    
      
        
           

        

        
          -
5 -

          
            

          

        

        
           

        

      

    

     

    
      
        
          	
                   
      

                	
                	
                  The
      Company shall deliver written notice to the Holder or Holders of this
      Warrant and to any holders of the Warrant Securities of its intention to
      file a registration statement or Regulation A Offering Statement
      under the Act at least 60 days prior to the filing of such registration
      statement or offering statement, and the Holder or Holders and holders of
      Warrant Securities shall have 30 days thereafter to request in writing
      that the Company register or qualify the Warrant, Warrant Securities, or
      the Warrant Securities underlying the unexercised portion of this Warrant
      in accordance with this subsection (a).  Upon the delivery
      of such a written request within the specified time, the Company shall be
      obligated to include in its contemplated registration statement or
      offering statement all information necessary or advisable to register or
      qualify the Warrant, Warrant Securities or Warrant Securities underlying
      the unexercised portion of this Warrant for a public offering, if the
      Company does file the contemplated registration statement or offering
      statement; provided, however, that neither the delivery of the notice by
      the Company nor the delivery of a request by a Holder or by a holder of
      Warrant Securities shall in any way obligate the Company to file a
      registration statement or offering statement.  Furthermore,
      notwithstanding the filing of a registration statement or offering
      statement, the Company may, at any time prior to the effective date
      thereof, determine not to offer the securities to which the registration
      statement or offering statement relates, other than the Warrant, Warrant
      Securities and Warrant Securities underlying the unexercised portion of
      this Warrant.

                  

                  The
      Company shall comply with the requirements of this subsection (a) and
      the related requirements of subsection (g) at its own
      expense.  That expense shall include, but not be limited to,
      legal, accounting, consulting, printing, federal and state filing fees,
      NASD fees, out-of-pocket expenses incurred by counsel, accountants and
      consultants retained by the Company, and miscellaneous expenses directly
      related to the registration statement or offering statement and the
      offering.  However, this expense shall not include the portion
      of any underwriting commissions, transfer taxes and the underwriter's
      accountable and nonaccountable expense allowances attributable to the
      offer and sale of the Warrant, Warrant Securities and the Warrant
      Securities underlying the unexercised portion of this Warrant, all of
      which expenses shall be borne by the Holder or Holders of this Warrant and
      the holders of the Warrant Securities registered or
    qualified

                

        

         

      

    

    
      	
               
      

            	
              (b)

            	
              In
      the event that the Company registers or qualifies the Warrant, Warrant
      Securities or the Warrant Securities underlying the unexercised portion of
      this Warrant pursuant to subsection (a) above, the Company shall
      include in the registration statement or qualification, and the prospectus
      included therein, all information and materials necessary or advisable to
      comply with the applicable statutes and regulations so as to permit the
      public sale of the Warrant, Warrant Securities or the Warrant Securities
      underlying the unexercised portion of this Warrant.  As used in
      subsection (a) of this Section 7, reference to the Company's
      securities shall include, but not be limited to, any class or type of the
      Company's securities or the securities of any of the Company's
      subsidiaries or affiliates.

            

    

    

    
      
        
           

        

        
          -
6 -

          
            

          

        

        
           

        

      

    

    

    

    
      	
               
      

            	
              (c)

            	
              In
      addition to the registration rights described in subsection (a)
      above, the Company shall use its best efforts to register or qualify the
      Warrant and Warrant Securities within ninety (90) days of the date of this
      Warrant.  The Company shall deliver written notice to all
      Holders of this Warrant and holders of Warrant Securities, if any,
      advising them that the Company is proceeding with a registration statement
      or offering statement and that their Warrant and Warrant Securities will
      be included therein.  The Company will supply all information
      necessary or advisable for any such registration statements or offering
      statements at its own expense.

            

    

    

    
      	
               
      

            	
              (d)

            	
              As
      to each registration statement or offering statement, the Company's
      obligations contained in this Section 7 shall be conditioned upon a
      timely receipt by the Company in writing of the
  following:

            

    

    

    
      	
               
      

            	
              (i)

            	
              Information
      as to the terms of the contemplated public offering furnished by and on
      behalf of each Holder or holder intending to make a public distribution of
      the Warrant, Warrant Securities or Warrant Securities underlying the
      unexercised portion of the Warrant;
and

            

    

    

    
      	
               
      

            	
              (ii)

            	
              Such
      other information as the Company may reasonably require from such Holders
      or holders, or any underwriter for any of them, for inclusion in the
      registration statement or offering
statement.

            

    

    

    
      	
               
      

            	
              (e)

            	
              In
      each instance in which the Company shall take any action to register or
      qualify the Warrant, Warrant Securities or the Warrant Securities
      underlying the unexercised portion of this Warrant, if any, pursuant to
      this Section 7, the Company shall do the
  following:

            

    

    

    
      	
               
      

            	
              (i)

            	
              supply
      to Holder, or any successor or assign whose Warrant and Warrant Securities
      are being registered or qualified, two (2) manually signed copies of each
      registration statement or offering statement, and all amendments thereto,
      and a reasonable number of copies of the preliminary, final or other
      prospectus or offering circular, all prepared in conformity with the
      requirements of the Act and the rules and regulations promulgated
      thereunder, and such other documents as Holder shall reasonably
      request;

            

    

    

    
      	
               
      

            	
              (ii)

            	
              cooperate
      with respect to (A) all necessary or advisable actions relating to
      the preparation and the filing of any registration statements or offering
      statements, and all amendments thereto, arising from the provisions of
      this Section 7, (B) all reasonable efforts to establish an
      exemption from the provisions of the Act or any other federal or state
      securities statutes, (C) all necessary or advisable actions to
      register or qualify the public offering at issue pursuant to federal
      securities statutes and the state "blue sky" securities statutes of each
      jurisdiction that the Holders of the Warrant or holders of Warrant
      Securities shall reasonably request, and (D) all other necessary or
      advisable actions to enable the Holders of the Warrant and holders of the
      Warrant Securities to complete the contemplated disposition of their
      securities in each reasonably requested
  jurisdiction;

            

    

    

    
      
        
           

        

        
          -
7 -

          
            

          

        

        
           

        

      

    

    

    

    
      	
               
      

            	
              (iii)

            	
              keep
      all registration statements or offering statements to which this
      Section 7 applies, and all amendments thereto, effective under the
      Act for a period of at least nine (9) months after their initial
      effective date and cooperate with respect to all necessary or advisable
      actions to permit the completion of the public sale or other disposition
      of the securities subject to a registration statement or offering
      statement; and

            

    

    

    
      	
               
      

            	
              (iv)

            	
              indemnify
      and hold harmless each Holder of the Warrant, each holder of Warrant
      Securities, and each underwriter within the meaning of the Act for each
      such Holder or holder, from and against all losses, claims, damages, and
      liabilities, including, but not limited to, any and all expenses
      reasonably incurred in investigating, preparing, defending or settling any
      claim, arising from or relating to (A) any untrue or alleged untrue
      statement of a material fact contained in any registration statement or
      offering statement to which this Section 7 applies, or (B) any
      omission or alleged omission to state a material fact necessary to make
      the statements contained in a registration statement or offering statement
      to which this Section 7 applies not misleading; provided, however,
      that the indemnification contained in this provision (iv) shall not
      apply if the untrue statement or omission, or alleged untrue statement or
      omission, was the result of information furnished in writing to the
      Company by the Holder, holder or underwriter seeking indemnification
      expressly for use in the registration statement or offering statement at
      issue.  To the extent that the indemnification contained in this
      provision applies, the Company also shall indemnify and hold harmless each
      officer, director, employee, controlling person or agent of an indemnified
      Holder, holder or underwriter.

            

    

    

    
      	
               
      

            	
              (f)

            	
              In
      each instance in which pursuant to this Section 7 the Company shall
      take any action to register or qualify the Warrant, Warrant Securities or
      the Warrant Securities underlying the unexercised portion of this Warrant,
      prior to the effective date of any registration statement or offering
      statement, the Company and each Holder or holder of Warrants or Warrant
      Securities being registered or qualified shall enter into reciprocal
      indemnification agreements, in the form customarily used by reputable
      investment bankers with respect to public offerings of securities,
      containing substantially the same terms as described in
      subsection (e)(iv) above.  These indemnification agreements
      also shall contain an agreement by the Holder or shareholder at issue to
      indemnify and hold harmless the Company, its officers, directors from and
      against any and all losses, claims, damages and liabilities, including,
      but not limited to, all expenses reasonably incurred in investigating,
      preparing, defending or settling any claim, directly resulting from any
      untrue statements of material facts, or omissions to state a material fact
      necessary to make a statement not misleading, contained in a registration
      statement or offering statement to which this Section 7 applies, if,
      and only if, the untrue statement or omission directly resulted from
      information provided in writing to the Company by the indemnifying Holder
      or shareholder expressly for use in the registration statement or offering
      statement at issue.

            

    

    

    
      
        
           

        

        
          -
8 -

          
            

          

        

        
           

        

      

    

    

    

    
      	
               
      

            	
              (g)

            	
              The
      term "Majority Holder" as used in this Section 7 shall include any
      Holder, any holder of Warrant Securities, or any combination of Holders
      and such holders of Warrant Securities, if they hold, in the aggregate,
      unexercised Warrants plus issued and outstanding Warrant Securities equal
      to more than 50% of the total of (i) all Warrant Securities issued
      and outstanding as a result of the exercise of the Warrant, and
      (ii) all Warrant Securities that may at that time be purchased by
      exercising the unexercised portion of the Warrant.  For purposes
      hereof, a Warrant entitling the Holder to purchase more than one Warrant
      Security shall be deemed to hold Warrants equal to the number of Warrant
      Securities which may be acquired pursuant to any such
    Warrant.

            

    

     

    
      
        	
                 
      

              	
                (h)

              	
                The
      Company's obligations described in this Section 7 shall continue in
      full force and effect regardless of the exercise, surrender, cancellation
      or expiration of this Warrant.

              

      

      
         

        
          	
                   
      

                	
                  (i)

                	
                  The
      registration rights provided under this Section 7 shall not be applicable
      to an initial public offering of the Company’s Common Stock, nor for a
      period of six (6) months following the initial public offering of the
      Company’s Common Stock.

                

        

         

      

    

    
      	
              6. 

            	
              Maximum
      Exercise.  The Holder shall not be entitled to exercise
      this Warrant on an exercise date in connection with that number of shares
      of Common Stock which would be in excess of the sum
      of:  (i) the number of shares of Common Stock beneficially
      owned by the Holder and its Affiliates on an exercise date; and
      (ii) the number of shares of Common Stock issuable upon the exercise
      of this Warrant with respect to which the determination of this limitation
      is being made on an exercise date, which would result in beneficial
      ownership by the Holder and its Affiliates of more than 9.99% of the
      outstanding Common Stock on such date.  For the purposes of the
      immediately preceding sentence, beneficial ownership shall be determined
      in accordance with Section 13(d) of the Securities Exchange Act
      of 1934, as amended, and Regulation 13d-3 thereunder.  Subject
      to the foregoing, the Holder shall not be limited to aggregate exercises
      which would result in the issuance of more than 9.99%.  The
      restriction described in this Section may be waived, in whole or in
      part, upon sixty-one (61) days prior notice from the Holder to the
      Company.  The Holder may allocate which of the equity of the
      Company deemed beneficially owned by the Subscriber shall be included in
      the 9.99% amount described above and which shall be allocated to the
      excess above 9.99%.

            

    

     

    
      
        	
                7. 

              	Transfer to Comply
      With the Securities Act of 1933.

      

       

    

    
      	
               
      

            	
              (a)

            	
              This
      Warrant, the Warrant Securities, and all other securities issued or
      issuable upon exercise of this Warrant, may not be offered, sold or
      transferred, in whole or in part, except in compliance with the Act, and
      except in compliance with all applicable state securities
      statutes.

            

    

    

    
      	
               
      

            	
              (b)

            	
              The
      Company may cause the following legend, or its equivalent, to be set forth
      on each certificate representing the Warrant Securities, or any other
      security issued or issuable upon exercise of this Warrant, not theretofore
      distributed to the public or sold to underwriters, as defined by the Act,
      for distribution to the public pursuant to Section 5
      above:

            

    

    

    
      
        
           

        

        
          -
9 -

          
            

          

        

        
           

        

      

    

    

    

    
      	
               
      

            	
              "The
      securities represented by this Certificate have not been registered under
      the Securities Act of 1933 ("the Act") and are 'restricted securities' as
      that term is defined in Rule 144 under the Act.  The
      securities may not be offered for sale, sold or otherwise transferred
      except pursuant to an effective registration statement under the Act or
      pursuant to an exemption from registration under the Act, the availability
      of which is to be established to the satisfaction of the
      Company."

            

    

    

    
      	
              
                8.

              

            	
            	
              Fractional
      Shares.  No fractional shares or scrip representing
      fractional shares shall be issued upon the exercise of all or any part of
      this Warrant.  With respect to any fraction of a share of any
      security called for upon any exercise of this Warrant, the Company shall
      pay to the Holder an amount in money equal to that fraction multiplied by
      the current market value of that share.  The current market
      value shall be determined as
follows:

            

    

    

    
      	
               
      

            	
              (i)

            	
              if
      the security at issue is listed on a national securities exchange or
      admitted to unlisted trading privileges on such an exchange or listed on
      the National Association of Securities Dealers National Market System, the
      current value shall be the last reported sale price of that security on
      such exchange or system on the last business day prior to the date of the
      applicable exercise of this Warrant or, if no such sale is made on such
      day, the average of the highest closing bid and lowest asked price for
      such day on such exchange or system;
or

            

    

    

    
      	
               
      

            	
              (ii)

            	
              if
      the security at issue is not so listed or admitted to unlisted trading
      privileges, the current market value shall be the average of the last
      reported highest bid and lowest asked prices quoted on the National
      Association of Securities Dealers Automated Quotations System or, if not
      so quoted, then by the National Quotation Bureau, Inc. on the last
      business day prior to the day of the applicable exercise of this Warrant;
      or

            

    

    

    
      	
               
      

            	
              (iii)

            	
              if
      the security at issue is not so listed or admitted to unlisted trading
      privileges and bid and asked prices are not reported, the current market
      value shall be determined in such reasonable manner as may be prescribed
      from time to time by the Board of Directors of the Company, subject to the
      arbitration procedure as described in Section 14 below if a Holder
      delivers written notice to the Company of an objection within thirty (30)
      days after the Board’s decision.

            

    

    

    
      	
              
                9.

              

            	
            	
              Rights of the
      Holder.  The Holder shall not be entitled to any rights
      as a shareholder in the Company by reason of this Warrant, either at law
      or equity, except as specifically provided for herein.  The
      Company covenants, however, that for so long as this Warrant is at least
      partially unexercised, it will furnish any Holder of this Warrant with
      copies of all reports and communications furnished to the shareholders of
      the Company.

            

    

    

    
      	
              10.

            	
              Charges Due Upon
      Exercise.  The Company shall pay any and all issue or
      transfer taxes, including, but not limited to, all federal or state taxes,
      that may be payable with respect to the transfer of this Warrant or the
      issue or delivery of Warrant Securities upon the exercise of this
      Warrant.

            

    

    

    
      
        
           

        

        
          -
10 -

          
            

          

        

        
           

        

      

    

    

    

    
      	
              11.

            	
              Warrant Securities to
      be Fully Paid.  The Company covenants that all Warrant
      Securities that may be issued and delivered to a Holder of this Warrant
      upon the exercise of this Warrant will be, upon such delivery, validly and
      duly issued, fully paid and
nonassessable.

            

    

    

    
      	
              12.

            	
              Notices.  All
      notices, certificates, requests, or other similar items provided for in
      this Warrant shall be in writing and shall be personally delivered or
      deposited in the United States mail, postage prepaid, addressed to the
      respective party as indicated in the portions of this Warrant preceding
      Section 1.  All notices shall be deemed to be delivered
      upon personal delivery or upon the expiration of three (3) business days
      following deposit in the United States mail, postage
      prepaid.  The addresses of the parties may be changed, and
      addresses of other Holders and holders of Warrant Securities may be
      specified, by written notice delivered pursuant to this
      Section 12.  The Company's principal office shall be deemed
      to be the address provided pursuant to this Section for the delivery of
      notices to the Company.

            

    

    

    
      	
              13.

            	
              Applicable
      Law.  This Warrant shall be governed by and construed in
      accordance with the laws of the State of Colorado, and courts located in
      Colorado shall have exclusive jurisdiction over all disputes arising
      hereunder except as provided in Section 14
  hereof.

            

    

    

    
      
        	
                14.

              	
                
                  Dispute
      Resolution.  The parties shall attempt in good faith to
      resolve any controversy or claim arising out of or relating to this
      Warrant, or the breach, termination, or validity thereof (a “Dispute”)
      promptly by negotiation between the parties.  If a Dispute has
      not been resolved within thirty (30) days by negotiation, the parties
      shall attempt to mediate the Dispute through the selection of a mutually
      agreeable mediator who shall conduct such mediation in
      confidence.  If a Dispute is not resolved by mediation, then the
      Dispute shall be settled by arbitration in accordance with the Commercial
      Arbitration Rules of the American Arbitration Association, and governed by
      the United States Arbitration Act, 9 U.S.C. §§ 1-16, except as otherwise
      provided herein.  Judgment upon the award rendered by the
      arbitrator may be entered by any court having jurisdiction
      thereof.  The place of arbitration shall be Denver,
      Colorado.  Each party shall be responsible for his own attorney
      fees incurred during any phase of dispute resolution.  The
      arbitrator shall apply the law to the dispute in the same manner as a
      judge as though the dispute was before a court of law of the State of
      Colorado.  The arbitrator shall have the authority to award any
      remedy or relief that a court of the State of Colorado could order or
      grant, including, without limitation, specific performance of any
      obligation created under the Agreement, the issuance of an injunction, or
      the imposition of sanctions for abuse or frustration of the arbitration
      process.  Notwithstanding the foregoing, the arbitrator shall
      not have authority to award punitive damages.  The parties shall
      take all reasonable steps necessary to conduct a hearing no later than
      forty-five (45) days after submission of the matter to
      arbitration.  The arbitrator shall render his decision within
      fifteen (15) days after the close of the arbitration
      hearing.  The arbitration award shall be in writing and shall
      specify the factual and legal bases for the
  award.

                

              

      

    

    

    
      
        
           

        

        
          -
11 -

          
            

          

        

        
           

        

      

    

    

    
       

      
        	
                15. 

              	Miscellaneous
      Provisions.

      

    

    

    
      	
               
      

            	
              (a)

            	
              Subject
      to the terms and conditions contained herein, this Warrant shall be
      binding on the Company and its successors and shall inure to the benefit
      of the original Holder, its successors and assigns and all holders of
      Warrant Securities and the exercise of this Warrant in full shall not
      terminate the provisions of this Warrant as it relates to holders of
      Warrant Securities.

            

    

    

    
      	
               
      

            	
              (b)

            	
              If
      the Company fails to perform any of its obligations hereunder, it shall be
      liable to the Holder for all damages, costs and expenses resulting from
      the failure, including, but not limited to, all reasonable attorney's fees
      and disbursements.

            

    

    

    
      	
               
      

            	
              (c)

            	
              This
      Warrant cannot be changed or terminated or any performance or condition
      waived in whole or in part except by an agreement in writing signed by the
      party against whom enforcement of the change, termination or waiver is
      sought.

            

    

    

    
      	
               
      

            	
              (d)

            	
              If
      any provision of this Warrant shall be held to be invalid, illegal or
      unenforceable, such provision shall be severed, enforced to the extent
      possible, or modified in such a way as to make it enforceable, and the
      invalidity, illegality or unenforceability shall not affect the remainder
      of this Warrant.

            

    

    

    
      	
               
      

            	
              (e)

            	
              The
      Company agrees to execute such further agreements, conveyances,
      certificates and other documents as may be reasonably requested by the
      Holder to effectuate the intent and provisions of this
      Warrant.

            

    

    

    
      	
               
      

            	
              (f)

            	
              Paragraph
      headings used in this Warrant are for convenience only and shall not be
      taken or construed to define or limit any of the terms or provisions of
      this Warrant.  Unless otherwise provided, or unless the context
      shall otherwise require, the use of the singular shall include the plural
      and the use of any gender shall include all
  genders.

            

    

    

     

    
      
        
          
            
              	 	  

                      ATTEST:

                    	 	 OMNI BIO PHARMACEUTICAL, INC.
	 	 	 	 
	
                        By   

                    	____________________________________	
                       By    

                    	____________________________________ 
	 	Bob
      Ogden   	 	
                      Edward
      Larkin

                    
	 	
                      Secretary

                    	 	
                      Chief
      Operating Officer

                    
	 	 	 	 

            

          

        

      

    

     

    

    
      
        
           

        

        
          -
12 -

          
            

          

        

        
           

        

      

    

    

    EXHIBIT
A

    

    NOTICE
OF EXERCISE

    

    (To be
executed by a Holder desiring to exercise the right to purchase Shares pursuant
to a Warrant.)

    

    The undersigned Holder of a Warrant
hereby

    

    
      	
              (a)

            	
              irrevocably
      elects to exercise the Warrant to the extent of purchasing _______________
      Shares;

            

    

    

    
      
        
          	
                  (b)

                	
                  makes
      payment in full of the aggregate Exercise Price for those Shares in the
      amount of $ ___________ by
      the delivery of immediately available funds in the amount of $ ________
      ;

                

        

      

    

    

    
      	
              (c)

            	
              requests
      that certificates evidencing the securities underlying such Shares be
      issued in the name of the undersigned, or, if the name and address of some
      other person is specified below, in the name of such other
      person:

            

    

    

     

    __________________________________________________

    

    __________________________________________________

    

    __________________________________________________

    (Name and
address of person other than
the

    undersigned
in whose name Shares are to be registered)

    

    
      	
              (d)

            	
              requests,
      if the number of Shares purchased are not all the Shares purchasable
      pursuant to the unexercised portion of the Warrant, that a new Warrant of
      like tenor for the remaining Shares purchasable pursuant to the Warrant be
      issued and delivered to the undersigned at the address stated
      below.

            

    

     

    

     

    
      	
              Dated:
      _______________________

            	 
      	 
      
	 
      	 
      	
              Signature
      ______________________________________

            
	 
      	 
      	
              (This
      signature must conform in all respects

              to
      the name of the Holder as specified on the

              face
      of the Warrant.)

            
	 
      	 
      	 
      
	
               ____________________________________

            	 
      	 
      
	
              Social
      Security Number or Employer ID Number

            	 
      	
              _____________________________________

            
	 
      	 
      	
              Printed
      Name

            
	 
      	 
      	 
      
	 
      	
               Address:    

            	
              _____________________________________

               

              _____________________________________

            

    

    

    

    
      
        
           

        

        
          - 13
-

          
            

          

        

        
           

        

      

    

    

    

    EXHIBIT
B

    

    ASSIGNMENT
FORM

    

    

    FOR VALUE
RECEIVED, the undersigned,, hereby sells, assigns and transfers
unto:

    

    Name:    ______________________________________________________

    (Please type or print in block
letters)

    

    Address: ______________________________________________________

    
 

    

    the right
to purchase  ____________ Shares of Omni Bio Pharmaceutical, Inc. (the
"Company") pursuant to the terms and conditions of the Warrant held by the
undersigned.  The undersigned hereby authorizes and directs the
Company (i) to issue and deliver to the above-named assignee at the above
address a new Warrant pursuant to which the rights to purchase being assigned
may be exercised, and (ii) if there are rights to purchase Shares remaining
pursuant to the undersigned's Warrant after the assignment contemplated herein,
to issue and deliver to the undersigned at the address stated below a new
Warrant evidencing the right to purchase the number of Shares remaining after
issuance and delivery of the Warrant to the above-named
assignee.  Except for the number of Shares purchasable, the new
Warrants to be issued and delivered by the Company are to contain the same terms
and conditions as the undersigned's Warrant.  To complete the
assignment contemplated by this Assignment Form, the undersigned hereby
irrevocably constitutes and
appoints ____________________________________ as the undersigned's
attorney-in-fact to transfer the Warrants and the rights thereunder on the books
of the Company with full power of substitution for these purposes.

     

    

     

    
      	
              Dated:
      _______________________________

            	 
      	 
      
	 
      	 
      	
              Signature
      _____________________________________

            
	 
      	 
      	
              (This
      signature must conform in all respects

              to
      the name of the Holder as specified on the

              face
      of the Warrant.)

            
	 
      	 
      	 
      
	
               ____________________________________

            	 
      	 
      
	
              Social
      Security Number or Employer ID Number

            	 
      	
               _____________________________________

            
	 
      	 
      	
              Printed
      Name

            
	 
      	 
      	 
      
	 
      	
               Address:    

            	
              _____________________________________

               

              _____________________________________

            

    

    

    

    - 14 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00160-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00160-of-00352.parquet"}]]